NCT06193343

Brief Summary

Optimal knee joint loading, which refers to the forces acting on the knee caused by daily activities such as daily steps, plays an essential role in maintaining knee articular cartilage health and reducing the risk of osteoarthritis (OA). After anterior cruciate ligament reconstruction (ACLR), individuals take fewer daily steps as compared to uninjured controls resulting in insufficient knee joint loading to joint tissues, but it is unclear how changes in daily steps impact knee joint cartilage health in OA development. Therefore, the overall single arm, longitudinal pre-test post-test study objective is to determine the mechanistic links between knee joint loading as measured by daily steps and comprehensive magnetic resonance imaging (MRI) measures of knee joint cartilage health post-ACLR. The central hypothesis is that individuals post-ACLR who take low daily steps will demonstrate deconditioned, less resilient cartilage characterized by poor tibiofemoral cartilage composition and greater cartilage strain.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
56

participants targeted

Target at P25-P50 for not_applicable

Timeline
20mo left

Started Sep 2024

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress51%
Sep 2024Jan 2028

First Submitted

Initial submission to the registry

December 21, 2023

Completed
15 days until next milestone

First Posted

Study publicly available on registry

January 5, 2024

Completed
9 months until next milestone

Study Start

First participant enrolled

September 23, 2024

Completed
3.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 30, 2028

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 30, 2028

Last Updated

April 29, 2026

Status Verified

April 1, 2026

Enrollment Period

3.4 years

First QC Date

December 21, 2023

Last Update Submit

April 23, 2026

Conditions

Outcome Measures

Primary Outcomes (17)

  • T2 relaxation times in the medial femoral condyle

    MRI marker of T2 relaxation times of medial femoral articular cartilage (i.e collagen organization) at pre-intervention (baseline)

    pre-intervention (baseline)

  • T2 relaxation times in the lateral femoral condyle

    MRI marker of T2 relaxation times of lateral femoral articular cartilage (i.e collagen organization) at pre-intervention (baseline)

    pre-intervention (baseline)

  • T2 relaxation times in the medial tibial condyle

    MRI marker of T2 relaxation times of medial tibial articular cartilage (i.e collagen organization) at pre-intervention (baseline)

    pre-intervention (baseline)

  • T2 relaxation times in the lateral tibial condyle

    MRI marker of T2 relaxation times of lateral tibial articular cartilage (i.e collagen organization) at pre-intervention (baseline)

    pre-intervention (baseline)

  • Change in T2 relaxation times in the medial femoral condyle

    Change in MRI marker of T2 relaxation times of medial femoral articular cartilage (i.e collagen organization) from pre-intervention to post-intervention

    pre-intervention (baseline), post-intervention (~18 weeks)

  • Change in T2 relaxation times in the lateral femoral condyle

    Change in MRI marker of T2 relaxation times of lateral femoral articular cartilage (i.e collagen organization) from pre-intervention to post-intervention

    post-intervention (~18 weeks)

  • Change in T2 relaxation times in the medial tibial condyle

    Change in MRI marker of T2 relaxation times of medial tibial articular cartilage (i.e collagen organization) from pre-intervention to post-intervention

    pre-intervention (baseline), post-intervention (~18 weeks)

  • Change T2 relaxation times in the lateral tibial condyle

    Change in MRI marker of T2 relaxation times of lateral tibial articular cartilage (i.e collagen organization) from pre-intervention to post-intervention

    pre-intervention (baseline), post-intervention (~18 weeks)

  • Average cartilage strain in the medial femoral condyle

    MRI marker of cartilage strain (i.e., acute change in cartilage thickness/resting cartilage thickness) of medial femoral articular cartilage at pre-intervention (baseline)

    pre-intervention (baseline)

  • Average cartilage strain in the lateral femoral condyle

    MRI marker of cartilage strain (i.e., acute change in cartilage thickness/resting cartilage thickness) of lateral femoral articular cartilage at pre-intervention (baseline)

    pre-intervention (baseline)

  • Average cartilage strain in the medial tibial condyle

    MRI marker of cartilage strain (i.e., acute change in cartilage thickness/resting cartilage thickness) of medial tibial articular cartilage at pre-intervention (baseline)

    pre-intervention (baseline)

  • Average cartilage strain in the lateral tibial condyle

    MRI marker of cartilage strain (i.e., acute change in cartilage thickness/resting cartilage thickness) of lateral tibial articular cartilage at pre-intervention (baseline)

    pre-intervention (baseline)

  • Change in average cartilage strain in the medial femoral condyle

    Change in MRI marker of cartilage strain (i.e., acute change in cartilage thickness/resting cartilage thickness) of medial femoral articular cartilage from pre-intervention to post-intervention

    pre-intervention (baseline), post-intervention (~18 weeks)

  • Change in average cartilage strain in the lateral femoral condyle

    Change in MRI marker of cartilage strain (i.e., acute change in cartilage thickness/resting cartilage thickness) of lateral femoral articular cartilage from pre-intervention to post-intervention

    pre-intervention (baseline), post-intervention (~18 weeks)

  • Change in average cartilage strain in the medial tibial condyle

    Change in MRI marker of cartilage strain (i.e., acute change in cartilage thickness/resting cartilage thickness) of medial tibial articular cartilage from pre-intervention to post-intervention

    pre-intervention (baseline), post-intervention (~18 weeks)

  • Change in average cartilage strain in the lateral tibial condyle

    Change in MRI marker of cartilage strain (i.e., acute change in cartilage thickness/resting cartilage thickness) of lateral tibial articular cartilage from pre-intervention to post-intervention

    pre-intervention (baseline), post-intervention (~18 weeks)

  • Daily steps

    Average steps per day over 7 day physical activity monitor wear at pre-intervention (baseline)

    Pre-intervention (baseline)

Other Outcomes (2)

  • Change in daily steps

    Pre-intervention (baseline), post-intervention (~18 weeks)

  • Change in Knee Injury and Osteoarthritis Outcome Score Quality of Life subscale

    Pre-intervention (baseline), post-intervention (~18 weeks)

Study Arms (1)

Interventional Group

EXPERIMENTAL

Participants who meet study criteria and are enrolled in adaptive daily step promotion intervention

Behavioral: Adaptive Daily Step Promotion

Interventions

Participants will wear a Fitbit monitor on their non-dominant wrist during a 10 to 14 day "run-in" screening to capture daily steps reported by the Fitbit but no daily step goals will be sent to the participant. The Fitbit monitor will be worn during all waking hours except water activities, and compliance will be considered as a day with ≥1,000 steps. Next, participants will undergo a 16-week intervention wearing the Fitbit monitor on their wrist and receive a text message each morning with a personalized, adaptive daily step count goal and a link used to confirm receipt of the goal. The preceding 10 days of step data will be rank ordered and the 60th percentile step count will be set as the goal for the next day. Goals will not exceed 10,000 daily steps.

Interventional Group

Eligibility Criteria

Age16 Years - 40 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Provision of signed and dated informed consent form
  • For children, signed and dated informed assent by child and parental permission form by parent/guardian to participate in the study
  • Underwent an anterior cruciate ligament reconstruction (ACLR) between 6-60 months prior to enrollment
  • Stated willingness to comply with all study procedures and lifestyle considerations and availability for the duration of the study
  • Completed all other formal physical therapy and therapeutic exercise regimens, and will not be engaging in any other formal therapy for their ACLR during the study
  • Physician clearance for unrestricted activity
  • Owning a smartphone
  • Demonstrate \< 8,000 steps per day during the screening phase of aim 2 as assessed using the Actigraph Link monitor

You may not qualify if:

  • Underwent an ACLR revision surgery due to a previous anterior cruciate ligament (ACL) graft injury
  • A multiple ligament surgery was indicated with their ACL injury
  • A lower extremity fracture was suffered during the ACL injury
  • The participant has previously been diagnosed with any diseases that affect joints is present in either knee including knee osteoarthritis inflammatory arthritis
  • Pregnant or plans to become pregnant over next 4 months
  • Body mass index (BMI) ≥ 36 kg/m2
  • Unable to speak English
  • Cochlear implant
  • Metal in body (metal fragments, shrapnel, permanent make-up, body piercings that cannot be removed)
  • Claustrophobia
  • History of seizures
  • Pacemaker

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Georgia

Athens, Georgia, 30602, United States

RECRUITING

MeSH Terms

Conditions

Anterior Cruciate Ligament Injuries

Condition Hierarchy (Ancestors)

Knee InjuriesLeg InjuriesWounds and Injuries

Study Officials

  • Caroline Lisee, PhD

    University of Georgia

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Caroline Lisee, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: single arm, longitudinal pre-test post-test study design
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 21, 2023

First Posted

January 5, 2024

Study Start

September 23, 2024

Primary Completion (Estimated)

January 30, 2028

Study Completion (Estimated)

January 30, 2028

Last Updated

April 29, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will share

Upon completion of the of the proposed projects, the overall data set will include outcome measures including: * Participant demographics * Knee injury history * ACLR surgical procedure data * Patient reported outcomes of self-reported knee function, physical activity, and psychological recovery * Daily steps throughout the intervention using a Fitbit * Daily steps before and after the intervention using a research grade tri-axial accelerometer * Habitual gait speed * Gait biomechanics at habitual gait speed * Magnetic resonance imaging (i.e., T1ρ, T2, and Dess)) of the tibiofemoral and patellofemoral joint All of the information will be linked together, but deidentified. The data will be available to those who submit a formal written request to the PI and commit to only using the data for researcher purposes unplanned by the investigators. The data cannot be used to recruit or contact participants and must be destroyed or returned following the data analysis.

Shared Documents
STUDY PROTOCOL, ICF
Time Frame
Data will be available for 10 years once all formal data collection, processing, and primary analysis is complete.
Access Criteria
The data will be available to those who submit a formal written request to the PI and commit to only using the data for researcher purposes unplanned by the investigators.

Locations